24/7 Market News Snapshot 23 October, 2025 – Genprex, Inc. Common Stock (NASDAQ:GNPX)

October 23, 2025

DENVER, Colo., 23 October, 2025 (www.247marketnews.com) – (NASDAQ:GNPX) are discussed in this article.
Genprex, Inc., a trailblazer in the field of gene therapy focused on treating cancer and diabetes, is currently demonstrating significant market momentum, with shares increasing to $11.711, a rise of 6.85% from the previous close of $10.960. In a display of strong investor interest, the trading volume reached 3.91 million, indicating a bullish trend that could be fueled by recent advancements and strategic initiatives undertaken by the company.

In a notable development, Genprex announced the successful completion of a definitive agreement for the issuance and sale of 243,622 shares of its common stock at $11.21 per share. This registered direct offering is projected to generate gross proceeds of approximately $2.7 million, with an additional potential of $5.4 million through concurrent short-term warrants, which allow investors to purchase up to 487,244 more shares at an exercise price of $11.00. The closing of this offering is set for October 24, 2025, subject to customary closing conditions, and is facilitated by H.C. Wainwright & Co.

The net proceeds from this transaction will support working capital and further corporate initiatives as Genprex advances its innovative portfolio, which includes Oncoprex®, a targeted gene therapy system aimed at treating lung cancer. The company is also exploring groundbreaking therapies for diabetes, reflecting its commitment to reshaping treatment approaches.

As Genprex forges ahead with its clinical trials and FDA collaborations, it stands at the forefront of potential therapeutic advancements in gene therapy. The firm’s ongoing dedication to developing impactful treatments positions it to significantly enhance patient care, drawing attention from investors and stakeholders alike as it prepares for upcoming milestones in its research and development endeavors.

Related news for (GNPX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.